Loading…
Filana Therapeutics, Inc. is projected to rise to $1.19 by 2027, a +16% move from its current price of $1.03. FLNA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.9946 | $1.03 | $1.07 | +0.01% |
| Aug 6 | $0.9804 | $1.03 | $1.08 | +0.01% |
| Aug 7 | $0.9696 | $1.03 | $1.09 | +0.02% |
| Aug 8 | $0.9606 | $1.03 | $1.10 | +0.02% |
| Aug 9 | $0.9527 | $1.03 | $1.11 | +0.03% |
| Aug 10 | $0.9457 | $1.03 | $1.12 | +0.03% |
| Aug 11 | $0.9393 | $1.03 | $1.13 | +0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.9393 | $1.03 | $1.13 | +0.04% |
| Week 2 | $0.9042 | $1.03 | $1.17 | +0.07% |
| Week 3 | $0.8783 | $1.03 | $1.21 | +0.11% |
| Week 4 | $0.8571 | $1.03 | $1.24 | +0.14% |
| Week 5 | $0.8389 | $1.03 | $1.27 | +0.18% |
| Week 6 | $0.8228 | $1.03 | $1.29 | +0.21% |
| Week 7 | $0.8082 | $1.03 | $1.32 | +0.25% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Filana Therapeutics, Inc. is a clinical stage biotechnology company focused on neurodegenerative diseases. Its lead therapeutic candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and its investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood.
The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. It was incorporated in 1998 and is based in Austin, Texas. The company operates in the Healthcare sector.
Filana Therapeutics, Inc. (FLNA) trades as a biotechnology stock in the Healthcare sector with a current price of $0.96. Its market capitalization is $46.38M and it ranks 4313 by market cap.
Forecasts indicate a bullish longer‑term price path, with the 2026 average price at $0.96 and rising to a 2050 average of $3.10, a 2050 maximum of $6.27, and a 2050 maximum return of 222.5%. The sentiment shifts from Neutral in 2026 to Bullish from 2028 onward. Additionally, the forecast projects 2027 average $1.12, 2028 average $1.22, 2029 average $1.27, and steady gains through 2035, 2040, and beyond, culminating in substantial long‑term upside.
A major floor 39.5% below — a decisive break under it would weaken the trend.
The nearest floor, 15.5% below — buyers have tended to step in here.
The nearest ceiling, 27.2% above — a clean break opens room to run.
A major ceiling 79.6% above — clearing it would confirm fresh momentum.
Key FLNA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FLNA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.924 | Buy | $0.9511 | Buy |
| MA 10 | $0.943 | Buy | $0.9662 | Buy |
| MA 20 | $1.05 | Sell | $1.03 | Buy |
| MA 50 | $1.21 | Sell | $1.18 | Sell |
| MA 100 | $1.42 | Sell | $1.43 | Sell |
| MA 200 | $2.05 | Sell | $2.08 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.80 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -25.31 | Neutral |
| Williams %R (14) | -39.13 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -8.18 | Sell |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 60.87 | Neutral |
| TRIX (15) | -1.03 | Sell |
| Awesome (5,34) | -0.19 | Sell |
| Ultimate (7,14,28) | 49.67 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 0.93 | Buy |
| ADX (14) | 30.49 | Sell |
| ATR (14) | 0.04 | Info |
The 30‑day technical picture is BEARISH.
RSI14 is 40, with a SMA50 of $1.21 and a SMA200 of $2.06.
Support is at $0.87 and resistance at $1.31. The 30‑day range runs from a low of $0.7656 to a high of $1.20.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.87 | $1.03 | $1.27 | 0% | Neutral | |
| $0.925 | $1.19 | $1.63 | +16% | Neutral | |
| $0.9793 | $1.31 | $1.88 | +27% | Bullish | |
| $0.9788 | $1.35 | $2.01 | +31% | Bullish | |
| $0.9079 | $1.29 | $1.97 | +25% | Bullish | |
| $0.8758 | $1.27 | $2.00 | +23% | Bullish | |
| $0.8636 | $1.28 | $2.07 | +25% | Bullish | |
| $0.9307 | $1.42 | $2.33 | +37% | Bullish | |
| $1.10 | $1.71 | $2.87 | +66% | Bullish | |
| $1.11 | $1.75 | $2.99 | +70% | Bullish | |
| $1.34 | $2.34 | $4.30 | +127% | Bullish | |
| $1.56 | $3.22 | $6.58 | +213% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.87 | $1.03 | $1.21 | +0.00% |
| September 2026 | $0.8621 | $1.03 | $1.26 | -0.24% |
| October 2026 | $0.8605 | $1.03 | $1.29 | +0.70% |
| November 2026 | $0.8202 | $0.9936 | $1.25 | -3.98% |
| December 2026 | $0.8201 | $1.00 | $1.27 | +0.66% |
Click any year to see its month-by-month FLNA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Filana Therapeutics, Inc.'s 2026 outlook centres on $1.03, within a $0.87 to $1.27 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, FLNA could reach as high as $1.63, with a base case around $1.19 and support toward $0.925 — roughly +16% from $1.03. A consolidation phase looks the most probable path here.
Expect FLNA to range from $0.9793 to $1.88 through 2028. The $1.31 average target implies a +27% move from current prices. That is up +10% on the projected 2027 average. Momentum favours further upside here.
The FLNA price prediction for 2029 points to an average of $1.35 (low $0.9788, high $2.01) — a potential gain of +31% on today's $1.03. Buyers look set to stay in control over this stretch.
In 2030, FLNA is projected to trade between $0.9079 and $1.97, averaging $1.29 — a potential gain of +25% from today's $1.03. That is -5% versus the projected 2029 average. Momentum favours further upside here.
Filana Therapeutics, Inc.'s 2031 outlook centres on $1.27, within a $0.8758 to $2.00 range. That is -1% versus the projected 2030 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, FLNA could reach as high as $2.07, with a base case around $1.28 and support toward $0.8636 — roughly +25% from $1.03. Momentum favours further upside here.
Expect FLNA to range from $0.9307 to $2.33 through 2033. The $1.42 average target implies a +37% move from current prices. That is up +10% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The FLNA price prediction for 2034 points to an average of $1.71 (low $1.10, high $2.87) — a potential gain of +66% on today's $1.03. Momentum favours further upside here.
In 2035, FLNA is projected to trade between $1.11 and $2.99, averaging $1.75 — a potential gain of +70% from today's $1.03. That is up +2% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Filana Therapeutics, Inc.'s 2040 outlook centres on $2.34, within a $1.34 to $4.30 range. That is up +34% on the projected 2035 average. That marks a +127% change versus current levels. Momentum favours further upside here.
By 2050, FLNA could reach as high as $6.58, with a base case around $3.22 and support toward $1.56 — roughly +213% from $1.03. Buyers look set to stay in control over this stretch.
Investing $1,000 in FLNA today (≈ 970.873786 FLNA) could be worth
$3,129.23
+$2,129.23 (+213%) by 2050 · US Dollar
Based on the average projected FLNA price of $3.22 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FLNAwould be worth at today's price.
$1,000 invested in FLNA on Jul 31, 2025 (≈ 476.190498 FLNA) would be worth
$490.48
-$509.52 (-51.0%) today · 0.49× · US Dollar
Based on a FLNA entry price of $2.1 vs. today's $1.03.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.89 | $1,157.3 | +15.7% |
| 1 month ago | $1.25 | $824 | -17.6% |
| 3 months ago | $1.51 | $682.12 | -31.8% |
| 6 months ago | $1.94 | $530.93 | -46.9% |
| 1 year ago | $2.1 | $490.48 | -51.0% |
| All time (5.0y) ago | $101.59 | $10.14 | -99.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FLNA forecast.
Our base-case forecast reaches $2.10 around 2040.
Implied market cap at $2.10: $101.45M
The multi‑year forecast portrays a bullish trajectory, with 2026 average price at $0.96 and 2050 average at $3.10, while the 2050 maximum reaches $6.27. The forecast also shows a 2050 ROI of 222.5% and a longer‑term bullish sentiment.
From 2028 onward, the outlook shifts to Bullish, with 2028 average $1.22, 2029 average $1.27, 2030 average $1.21, and further increases through 2031–2035, 2040, and 2050. The pattern suggests growing upside over the long horizon, though these remain estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.21 with a 25.9% ROI; the range is a min of $0.8569 and a max of $1.85.
The outlook shows a bullish path from 2028 to 2050, with an average price of $3.10 by 2050 and a 222.5% ROI, but these are estimates and not guaranteed.
The 2050 forecast max is $6.27, with a 2050 average of $3.10 and a 222.5% ROI.
Market cap is $46.38M and the rank is 4313.
Filana Therapeutics, Inc. Community Discussion
0Share your Filana Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.